Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2007.097469v1, 2007; 10.1373/clinchem.2007.097469
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2007.097469v1
54/2/326    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dodds, L.
Right arrow Articles by Joseph, K.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dodds, L.
Right arrow Articles by Joseph, K.S.

Received on September 6, 2007
Accepted on November 16, 2007

Endocrinology and Metabolism

Effect of Homocysteine Concentration in Early Pregnancy on Gestational Hypertensive Disorders and Other Pregnancy Outcomes

Linda Dodds 1*, Deshayne B. Fell 2, Kent C. Dooley 2, B. Anthony Armson 3, Alexander C. Allen 1, Bassam A. Nassar 4, Sherry Perkins 5, K.S. Joseph 1

1 Perinatal Epidemiology Research Unit, Departments of Obstetrics and Gynaecology and Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada
2 Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada
3 Department of Obstetrics and Gynaecology, Dalhousie University, Halifax, Nova Scotia, Canada
4 Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada, and Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
5 University of Ottawa and the Ottawa Hospital, Ottawa, Ontario, Canada

* To whom correspondence should be addressed. E-mail: l.dodds{at}dal.ca.

BACKGROUND: Increased total homocysteine (tHcy) may be associated with placental-mediated adverse pregnancy outcomes, but few prospective studies have measured tHcy before pregnancy outcome. This study was undertaken to determine whether increased tHcy measured in early pregnancy is associated with pregnancy loss, gestational hypertension (GH), preeclampsia, or small for gestational age (SGA) infants.

METHODS: We conducted a prospective cohort study between 2002 and 2005. We measured tHcy and serum folate in blood samples from pregnant women (<20 weeks' gestation) and collected detailed pregnancy information through a questionnaire and medical record review.

RESULTS: Of the 2119 women included in the study, 103 had a pregnancy loss, 115 had gestational hypertension, 65 had preeclampsia, and 129 had an SGA infant. Subjects with increased tHcy concentrations were at increased risk of pregnancy loss [relative risk (RR) 2.1, 95% CI 1.2–3.6] or preeclampsia (RR 2.7, 95% CI 1.4–5.0) than subjects with lower tHcy concentrations, but increased tHcy concentration was not associated with increased risk of developing GH or having an SGA infant.

CONCLUSION: The finding of high tHcy in early pregnancy as a risk factor for pregnancy loss and preeclampsia is consistent with a hypothesis that increased tHcy results in abnormalities of the placental vasculature.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Association for Clinical Chemistry.